Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A High-Fidelity and Ancestrally Inclusive Patient-Derived Organoid Platform Resolves Cancer Cell Plasticity in Uterine Carcinosarcoma.

bioRxiv : the preprint server for biology·2026
Same author

Microbial induction of MHC-II expression in colon cancer cells overcomes immunotherapy resistance and limits metastasis.

bioRxiv : the preprint server for biology·2026
Same author

A Single-Cell Atlas of Uterine Carcinosarcoma from Diverse Ancestries.

bioRxiv : the preprint server for biology·2026
Same author

Integrative Genomic, Transcriptomic, and Microbiome Profiles of Colon Cancer by Ancestry Provide Insights into Molecular Distinctions.

medRxiv : the preprint server for health sciences·2026
Same author

Diverse high-fat diets drive multi-omic reprogramming that persists after dietary reversal.

bioRxiv : the preprint server for biology·2026
Same author

Ancestrally Diverse Autologous Patient-Derived Organoid-Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcome Disparities in High-Grade Endometrial Cancer.

Cancer research communications·2026

Related Experiment Video

Updated: May 22, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K

IER3: exploring its dual function as an oncogene and tumor suppressor.

Meena Kanduri1, Santhilal Subhash2,3,4, Rossana Putino5

  • 1Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Meena.kanduri@gu.se.

Cancer Gene Therapy
|March 17, 2025
PubMed
Summary

The IER3 gene acts as both a tumor suppressor and oncogene in cancer. This study reveals molecular pathways, including epigenetic regulation of EGR2, that explain IER3

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.2K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K

Related Experiment Videos

Last Updated: May 22, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.4K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.2K
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

8.2K

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Gene Regulation

Background:

  • The IER3 gene exhibits dual roles in cancer, functioning as either a tumor suppressor or an oncogene, contingent on the specific cancer type.
  • The precise mechanisms governing IER3's context-dependent functions in cancer progression remain incompletely understood.
  • Elucidating these mechanisms is crucial for understanding cancer development and identifying therapeutic targets.

Purpose of the Study:

  • To investigate the molecular pathways mediating the switch between IER3's oncogenic and tumor suppressor functions.
  • To characterize the differential regulation of IER3 in cervical carcinoma and neuroblastoma cell lines.
  • To identify key genes and epigenetic mechanisms involved in IER3's dual roles.

Main Methods:

  • Utilized cervical carcinoma (HeLa) and neuroblastoma (NB) cell lines as model systems.
  • Analyzed gene expression patterns, focusing on immediate early response pathway genes like EGR2, FOS, and JUN.
  • Investigated epigenetic modulation of the EGR2 promoter.
  • Examined the role of the ADAM19 gene in IER3-mediated tumor suppression.

Main Results:

  • In HeLa cells, IER3 expression promoted an oncogenic program involving EGR2, FOS, and JUN.
  • In NB cells, IER3 suppressed the EGR2-dependent oncogenic program.
  • Epigenetic modulation of the EGR2 promoter was identified as a key mechanism for differential EGR2 regulation by IER3.
  • The ADAM19 gene was found to be critical for the tumor suppressor function of IER3 in NB cells.

Conclusions:

  • The study uncovers the molecular pathways dictating the context-dependent roles of IER3 in cancer.
  • Findings provide insights into the dual functionality of IER3, highlighting epigenetic regulation and specific gene interactions (EGR2, ADAM19).
  • This research contributes to a deeper understanding of cancer biology and the intricate mechanisms of gene regulation in disease.